QCast: Data-Driven Dialogue in Drug Development

Episode 3: Complex Innovative Trial Designs

Quanticate Episode 3

In this QCast episode, join Jullia and Tom as they unpack Complex Innovative Trial Designs (CIDs), exploring how adaptive and Bayesian methods – from response-adaptive randomisation to platform protocols – are transforming clinical research by boosting efficiency, personalisation, and speed.

Key Takeaways

  • What makes a trial 'complex and innovative': adaptive rules, Bayesian borrowing, and seamless master protocols.
  • Four CID categories: traditional adaptive, biomarker-guided, Bayesian borrowing, and platform vaccine trials.
  • How CIDs deliver faster timelines, smaller sample sizes, and more ethical patient allocation.
  • Essential preparation tips and guidelines for successful implementation.
  • Common pitfalls to avoid, including under-powered designs, data integrity issues, and mismatched external controls.


🔗 Learn More & Get Support: Visit quanticate.com to explore our biometrics services and discover how we can support your next clinical trial.
📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast.
🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode.

About Quanticate

Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in:

  • Clinical Data Capture & Management
  • Biostatistics & Statistical Consultancy
  • Statistical Programming & PK/PD Analysis
  • Medical Writing & Pharmacovigilance
  • Regulatory & Submission Support
  • AI & Automation
  • Post-Marketing Safety & Real-World Data

Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.